Viking Fund Management’s Core Laboratories CLB Stock Holding History

Viking Fund Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-64,000	Closed	-$2.41M	–	120
2019 Q4	$2.41M	Buy	64,000 +4,000	+7%	+$180K	0.68%	53
2019 Q3	$2.8M	Hold	60,000	–	–	0.8%	49
2019 Q2	$3.14M	Buy	+60,000	New	+$3.52M	0.83%	40
2018 Q1	–	Sell	-75,000	Closed	-$8.22M	–	124
2017 Q4	$8.22M	Buy	+75,000	New	+$7.49M	1.34%	25
2014 Q2	–	Sell	-30,000	Closed	-$5.95M	–	55
2014 Q1	$5.95M	Buy	+30,000	New	+$5.66M	0.83%	45

Other funds holding CLB

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Viking Fund Management's CLB Position: Q1 2020 in Review

Viking Fund Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 64,000 shares — an estimated $2.41M sold.

Viking Fund Management first reported a position in CLB in Q1 2014 and held it in 5 quarters. The position peaked at $8.22M in Q4 2017. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Viking Fund Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Viking Fund Management sold 64,000 Core Laboratories shares in Q1 2020, an estimated $2.41M.
Viking Fund Management first reported a position in Core Laboratories in Q1 2014 and held it in 5 quarters.
Viking Fund Management's Core Laboratories position peaked at $8.22M in Q4 2017.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Viking Fund Management's 13F filing for Q1 2020, filed 13 Apr 2020.